Rekombinanter DLL3 (Rovalpituzumab Biosimilar) Antikörper
Reaktivität: Human
FACS, SPR, Func, ELISA, BLI
Wirt: Human
Monoclonal
unconjugated
Recombinant Antibody
-
- Target Alle DLL3 (Rovalpituzumab Biosimilar) Produkte
- DLL3 (Rovalpituzumab Biosimilar)
- Antikörpertyp
- Recombinant Antibody
- Reaktivität
- Human
-
Wirt
-
Human
- Expressionssystem
- CHO Cells
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser DLL3 (Rovalpituzumab Biosimilar) Antikörper ist unkonjugiert
- Applikation
- Flow Cytometry (FACS), Surface Plasmon Resonance (SPR), Functional Studies (Func), ELISA, Bio-Layer Interferometry (BLI)
- Verwendungszweck
- Anti-DLL3 Reference Antibody (rovalpituzumab)
- Sequenz
- QVQLVQSGAE VKKPGASVKV SCKASGYTFT NYGMNWVRQA PGQGLEWMGW INTYTGEPTY ADDFKGRVTM TTDTSTSTAY MELRSLRSDD TAVYYCARIG DSSPSDYWGQ GTLVTVSSAS TKGPSVFPLA PSSKSTSGGT AALGCLVKDY FPEPVTVSWN SGALTSGVHT FPAVLQSSGL YSLSSVVTVP SSSLGTQTYI CNVNHKPSNT KVDKKVEPKS CDKTHTCPPC PAPELLGGPS VFLFPPKPKD TLMISRTPEV TCVVVDVSHE DPEVKFNWYV DGVEVHNAKT KPREEQYNST YRVVSVLTVL HQDWLNGKEY KCKVSNKALP APIEKTISKA KGQPREPQVY TLPPSRDELT KNQVSLTCLV KGFYPSDIAV EWESNGQPEN NYKTTPPVLD SDGSFFLYSK LTVDKSRWQQ GNVFSCSVMH EALHNHYTQK SLSLSPG,EIVMTQSPAT LSVSPGERAT LSCKASQSVS NDVVWYQQKP GQAPRLLIYY ASNRYTGIPA RFSGSGSGTE FTLTISSLQS EDFAVYYCQQ DYTSPWTFGQ GTKLEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
- Produktmerkmale
- Anti-DLL3 Reference Antibody (rovalpituzumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
- Reinheit
- >95 %
- Isotyp
- IgG1
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Kommentare
-
Therapeutic Agents by Target and Mechanism: DLL3 inhibitors
Conditions: Cancer Lung Cancer (advanced small cell)
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Konzentration
- 1 mg/mL
- Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
- Lagerung
- 4 °C,-80 °C
- Informationen zur Lagerung
- +4°C,-80°C
-
- Target
- DLL3 (Rovalpituzumab Biosimilar)
- Abstract
- DLL3 (Rovalpituzumab Biosimilar) Produkte
- Substanzklasse
- Biosimilar
- Hintergrund
- Synonyms: Delta Like Canonical Notch Ligand 3, D3
- Molekulargewicht
- 145.5 kDa
- UniProt
- Q9NYJ7
-
Sie sind hier:
